Glucagon API manufacturers

Glucagon is a 29-amino-acid hormone used for severe hypoglycaemia.

3 listed companies hold an active US Type II Drug Master File for Glucagon API, based in United States (1), Switzerland (1), Italy (1). 2 have a regulator record of GMP manufacturing.

Ordered by score. Scores follow the published rules and are not affected by paid placement. Updated 2026-11-13.

Glucagon API DMF holders (3)

Source: FDA Drug Master File list. Holding a DMF is a regulatory filing, not an FDA approval.

AmbioPharm
North Augusta, South Carolina, USA
High
GMPCOA

US peptide API CDMO with facilities in the US and China.

Model
CDMO
Manufacturer?
Yes
GMP CertifiedIn-House ProductionInternational Shipping
Bachem Holding AG
Bubendorf, Switzerland
High
GMPCOA

Swiss peptide and oligonucleotide CDMO with GMP plants in Europe and the US.

Model
CDMO
Manufacturer?
Yes
GMP CertifiedIn-House ProductionInternational Shipping
Fresenius Kabi iPSUM S.r.l.
Villadose (Rovigo), Italy
High

Fresenius Kabi's Italian API unit; its Villadose site near Venice develops and makes peptide APIs, also offered through Fresenius Kabi contract manufacturing. Holds US DMFs for 6 peptide APIs.

Model
CDMO
Manufacturer?
Yes
In-House ProductionWholesaleInternational Shipping

Other peptide APIs

Related

Frequently asked questions

Who manufactures Glucagon API?

Companies holding active US DMFs for Glucagon include AmbioPharm, Bachem Holding AG and Fresenius Kabi iPSUM S.r.l.. Other manufacturers may supply it without a US DMF.

Where are Glucagon API manufacturers based?

Among listed DMF holders: United States (1), Switzerland (1), Italy (1).

Does a DMF mean the API is FDA approved?

No. FDA reviews a DMF when a drug application references it and does not approve DMFs on their own.